Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pharmacol Ther. 2016 Jan 22;159:83–92. doi: 10.1016/j.pharmthera.2016.01.006

Fig. 4.

Fig. 4

Diagram of signaling pathways associated with VM that are affected by CVM-1118. After treating human melanoma cells with CVM-1118, changes in the mRNA, protein expression and phosphorylation of specific members of these different pathways were examined by q-RT-PCR, Western blot analyses, and the R&D Systems Proteome Profiler Antibody Arrays (i.e. Human Apoptosis, Human Phospho-Kinase, Human Phospho-MAPK and Human Cell Stress Arrays).